März 2018 - IOZK

Molecular signatures associated with tumor-specific immune response in melanoma patients treated with dendritic cell-based immunotherapy

2018-03-30/in Dendritic Cells, International Publications, Malignant Melanoma /von 2018-03-30 / Oncotarget 2018 Mar;9(24):17014-17027

Tumor lysate-based vaccines: on the road to immunotherapy for gallbladder cancer

2018-03-29/in Dendritic Cells, Gallbladder Cancer, International Publications /von 2018-03-29 / Cancer Immunol Immunother 2018 Dec;67(12):1897-1910

Optimized dendritic cell vaccination induces potent CD8 T cell responses and anti-tumor effects in transgenic mouse melanoma models

2018-03-26/in Dendritic Cells, International Publications, Malignant Melanoma /von 2018-03-26 / Oncoimmunology 2018;7(7):e1445457

Immunotherapy for Hepatocellular Carcinoma: Current Advances and Future Expectations

2018-03-26/in Dendritic Cells, Hepatocellular Carcinoma, International Publications /von 2018-03-26 / J Immunol Res 2018;2018:8740976

Dendritic cells as cancer therapeutics

2018-03-21/in Dendritic Cells, International Publications /von 2018-03-21 / Semin. Cell Dev. Biol. 2019 Feb;86:77-88

Proteomic Identification of Heat Shock-Induced Danger Signals in a Melanoma Cell Lysate Used in Dendritic Cell-Based Cancer Immunotherapy

2018-03-18/in Dendritic Cells, International Publications, Malignant Melanoma /von 2018-03-18 / J Immunol Res 2018;2018:3982942

Overexpression of p53 delivered using recombinant NDV induces apoptosis in glioma cells by regulating the apoptotic signaling pathway

2018-03-08/in Glioblastoma, International Publications, Newcastle Disease Virus /von 2018-03-08 / Exp Ther Med 2018 May;15(5):4522-4530

Randomized phase II trial of autologous dendritic cell vaccines versus autologous tumor cell vaccines in metastatic melanoma: 5-year follow up and additional analyses

2018-03-06/in Dendritic Cells, International Publications, Malignant Melanoma /von 2018-03-06 / J Immunother Cancer 2018 Mar;6(1):19

PD-L1 in tumor microenvironment mediates resistance to oncolytic immunotherapy

2018-03-05/in Checkpoint-Inhibitors, International Publications, Newcastle Disease Virus /von 2018-03-05 / J. Clin. Invest. 2018 Apr;128(4):1413-1428

Dendritic Cells and Programmed Death-1 Blockade: A Joint Venture to Combat Cancer

2018-03-01/in Checkpoint-Inhibitors, Dendritic Cells, International Publications /von 2018-03-01 / Front Immunol 2018;9:394